ESOMEPRAZOLE Side Effects

7015470-2 | Blister, Necrosis, Rash Erythematous
on Sep 14, 2010 Female patient from UNITED STATES , 60 years of age, was treated with Esomeprazole (View Usage). Patient experienced the following unwanted or unexpected effects: blister, necrosis, rash erythematous. Esomeprazole dosage: . During the same period patient was treated with PROPOFOL (View Propofol Review and Propofol Label ), BRICANYL (View Bricanyl Review and Bricanyl Label ), FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ), TERLIPRESSIN (View Terlipressin Review and Terlipressin Label ), PHENYLEPHRINE HCL (View Phenylephrine Hcl Review and Phenylephrine Hcl Label ), ISOTONIC SODIUM CHLORIDE (View Isotonic Sodium Chloride Review and Isotonic Sodium Chloride Label ), CALCIUM CHLORIDE DIHYDRATE (View Calcium Chloride Dihydrate Review and Calcium Chloride Dihydrate Label ), PROTHROMPLEX S TIM (View Prothromplex S-tim Review and Prothromplex S-tim Label ).

6733849-0 | Thrombocytopenia
Patient was taking Esomeprazole (View Usage). Patient had the following side effects: thrombocytopenia on May 11, 2010 from UNITED STATES Additional patient health information: Male patient , 55 years of age, was diagnosed with prophylaxis and. Esomeprazole dosage: . During the same period patient was treated with PHENYTOIN (View Phenytoin Review and Phenytoin Label ), FOSPHENYTOIN (Loading Dose) (View Fosphenytoin Review and Fosphenytoin Label ), ALBUMIN (HUMAN) (View Albumin (human) Review and Albumin (human) Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), DOBUTAMINE HCL (View Dobutamine Hcl Review and Dobutamine Hcl Label ), NOREPINEPHRINE (View Norepinephrine Review and Norepinephrine Label ), VASOPRESSIN (View Vasopressin Review and Vasopressin Label ).

6706567-2 | Hypocalcaemia, Hypomagnesaemia
Adverse event was reported on Apr 23, 2010 by a Female patient taking Esomeprazole (View Usage) (Dosage: ) was diagnosed with gastrooesophageal reflux disease, gravitational oedema and. Location: UNITED KINGDOM , 72 years of age, After Esomeprazole was administered, patient had the following side effects: hypocalcaemia, hypomagnesaemia. During the same period patient was treated with PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ), BENDROFLUMETHIAZIDE (View Bendroflumethiazide Review and Bendroflumethiazide Label ). Patient was hospitalized.

6660693-5 | Rhabdomyolysis
on Mar 22, 2010 Male patient from GERMANY , 75 years of age, was diagnosed with prophylaxis against gastrointestinal ulcer, sedation and was treated with Esomeprazole (View Usage). Patient experienced the following unwanted or unexpected effects: rhabdomyolysis. Esomeprazole dosage: 40-80 Mg/day. During the same period patient was treated with INSULIN (View Insulin Review and Insulin Label ), HEPARIN (800 Iu/h) (View Heparin Review and Heparin Label ), FUROSEMIDE (40-120 Mg/day) (View Furosemide Review and Furosemide Label ), AMIODARONE HCL (View Amiodarone Hcl Review and Amiodarone Hcl Label ), MEROPENEM (View Meropenem Review and Meropenem Label ), LINEZOLID (View Linezolid Review and Linezolid Label ), PROPOFOL (View Propofol Review and Propofol Label ), SUFENTANIL (View Sufentanil Review and Sufentanil Label ).


6634843-0 | Hypocalcaemia, Hypokalaemia, Hypomagnesaemia
on Mar 05, 2010 Male patient from NETHERLANDS , 81 years of age, was diagnosed with hyperkalaemia and was treated with Esomeprazole (View Usage). Patient had the following side effects: hypocalcaemia, hypokalaemia, hypomagnesaemia. Esomeprazole dosage: . During the same period patient was treated with ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), CALCIUM (View Calcium Review and Calcium Label ), ION EXCHANGE RESIN (View Ion-exchange Resin Review and Ion-exchange Resin Label ). Patient was hospitalized.

6634842-9 | Hypocalcaemia, Hypokalaemia, Hypomagnesaemia
Patient was taking Esomeprazole (View Usage). After Esomeprazole was administered, patient had the following side effects: hypocalcaemia, hypokalaemia, hypomagnesaemia on Mar 05, 2010 from NETHERLANDS Additional patient health information: Male patient , 63 years of age, . Esomeprazole dosage: . During the same period patient was treated with LISINOPRIL (View Lisinopril Review and Lisinopril Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), COUMARIN DERVIATIVE (View Coumarin Derviative Review and Coumarin Derviative Label ). Patient was hospitalized.

6632182-5 | Circulatory Collapse, Gait Disturbance, Hypocalcaemia, Hypomagnesaemia, Lethargy, Muscle Spasms, Paraesthesia, Tetany
Adverse event was reported on Mar 03, 2010 by a Female patient taking Esomeprazole (View Usage) (Dosage: ) was diagnosed with barrett's oesophagus and. Location: UNITED KINGDOM , 78 years of age, Patient experienced the following unwanted or unexpected effects: circulatory collapse, gait disturbance, hypocalcaemia, hypomagnesaemia, lethargy, muscle spasms, paraesthesia, tetany. During the same period patient was treated with PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), COLECALCIFEROL (View Colecalciferol Review and Colecalciferol Label ), ERGOCALCIFEROL (View Ergocalciferol Review and Ergocalciferol Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

6607859-8 | Hypocalcaemia
on Feb 19, 2010 Female patient from UNITED STATES , 50 years of age, was diagnosed with reflux laryngitis, hypoparathyroidism, hypocalcaemia and was treated with Esomeprazole (View Usage). Patient had the following side effects: hypocalcaemia. Esomeprazole dosage: . During the same period patient was treated with CALCIUM (View Calcium Review and Calcium Label ), CALCITRIOL (View Calcitriol Review and Calcitriol Label ).

6590331-1 | Circulatory Collapse, Gait Disturbance, Hypocalcaemia, Hypomagnesaemia, Lethargy, Muscle Spasms, Paraesthesia, Tetany
on Feb 10, 2010 Female patient from UNITED KINGDOM , 78 years of age, was diagnosed with barrett's oesophagus and was treated with Esomeprazole (View Usage). After Esomeprazole was administered, patient had the following side effects: circulatory collapse, gait disturbance, hypocalcaemia, hypomagnesaemia, lethargy, muscle spasms, paraesthesia, tetany. Esomeprazole dosage: . During the same period patient was treated with PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ), ALFACALCIDOL (View Alfacalcidol Review and Alfacalcidol Label ), CALCICHEW D3 (View Calcichew D3 Review and Calcichew D3 Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

6401803-4 | Femur Fracture
Patient was taking Esomeprazole (View Usage). Patient experienced the following unwanted or unexpected effects: femur fracture on Oct 06, 2009 from SWITZERLAND Additional patient health information: Female patient , 63 years of age, was diagnosed with osteopenia and. Esomeprazole dosage: . During the same period patient was treated with ALENDRONATE SODIUM (View Alendronate Sodium Review and Alendronate Sodium Label ), CALCIUM SUPPLEMENTATION (View Calcium Supplementation Review and Calcium Supplementation Label ). Patient was hospitalized.

6175758-4 | Jaundice Cholestatic
Adverse event was reported on Apr 29, 2009 by a Male patient taking Esomeprazole (View Usage) (Dosage: 40 Mg) was diagnosed with dyspepsia and. Location: UNITED KINGDOM , 77 years of age, Patient had the following side effects: jaundice cholestatic.

6171581-5 | Jaundice, Liver Function Test Abnormal
on Apr 20, 2009 Female patient from UNITED KINGDOM , 75 years of age, weighting 167.6 lb, was diagnosed with lower respiratory tract infection, epilepsy (What is epilepsy?), iron deficiency anaemia and was treated with Esomeprazole (View Usage). After Esomeprazole was administered, patient had the following side effects: jaundice (What is jaundice?), liver function test abnormal. Esomeprazole dosage: 40mg. During the same period patient was treated with AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ), AUGMENTIN '125' (1.2g) (View Augmentin '125' Review and Augmentin '125' Label ), KEPPRA (View Keppra Review and Keppra Label ), FERROUS FUMARATE (280mg) (View Ferrous Fumarate Review and Ferrous Fumarate Label ), LAMOTRIGINE (View Lamotrigine Review and Lamotrigine Label ), LANSOPRAZOLE (30mg) (View Lansoprazole Review and Lansoprazole Label ).

6158641-X | Amnesia, Anaemia, Cerebral Atrophy, Confusional State, Dementia, Gait Disturbance, Hypophagia, Sinus Tachycardia, Vitamin B12 Deficiency
on Mar 30, 2009 Female patient from UNITED STATES , 72 years of age, was diagnosed with abdominal discomfort and was treated with Esomeprazole (View Usage). Patient experienced the following unwanted or unexpected effects: amnesia, anaemia, cerebral atrophy, confusional state, dementia (What is dementia?), gait disturbance, hypophagia, sinus tachycardia, vitamin b12 deficiency. Esomeprazole dosage: Daily. During the same period patient was treated with FAMOTIDINE (Daily) (View Famotidine Review and Famotidine Label ), GINGER (View Ginger Review and Ginger Label ), GINSENG (View Ginseng Review and Ginseng Label ), GINKGO BILOBA (View Ginkgo Biloba Review and Ginkgo Biloba Label ), ECHINACEA /01323502/ (View Echinacea /01323502/ Review and Echinacea /01323502/ Label ). Patient was hospitalized.

6157741-8 | Amnesia, Anaemia, Asthenia, Blood Albumin Decreased, Cerebral Atrophy, Dementia, Gait Disturbance, Hypovitaminosis, Iron Deficiency
Patient was taking Esomeprazole (View Usage). Patient had the following side effects: amnesia, anaemia, asthenia, blood albumin decreased, cerebral atrophy, dementia (What is dementia?), gait disturbance, hypovitaminosis, iron deficiency on Mar 30, 2009 from UNITED STATES Additional patient health information: Female patient , 72 years of age, was diagnosed with abdominal discomfort and. Esomeprazole dosage: Daily. During the same period patient was treated with FAMOTIDINE (Daily) (View Famotidine Review and Famotidine Label ), GINGER (View Ginger Review and Ginger Label ), GINSENG (View Ginseng Review and Ginseng Label ), GINKGO BILOBA (View Ginkgo Biloba Review and Ginkgo Biloba Label ), ECHINACEA /01323502/ (View Echinacea /01323502/ Review and Echinacea /01323502/ Label ). Patient was hospitalized.

6039171-2 | Oesophagitis
Adverse event was reported on Nov 26, 2008 by a Female patient taking Esomeprazole (View Usage) (Dosage: ) was diagnosed with reflux oesophagitis, constipation (What is constipation?) and. Location: JAPAN , weighting 114.6 lb, After Esomeprazole was administered, patient had the following side effects: oesophagitis. During the same period patient was treated with PURSENNID (As Required) (View Pursennid Review and Pursennid Label ), LAXOBERON (Optimal Dose As Required) (View Laxoberon Review and Laxoberon Label ). Patient was hospitalized.

5899896-6 | Hypocalcaemia
on Sep 22, 2008 Female patient from UNITED STATES , 33 years of age, was diagnosed with gastrooesophageal reflux disease, blood calcium and was treated with Esomeprazole (View Usage). Patient experienced the following unwanted or unexpected effects: hypocalcaemia. Esomeprazole dosage: . During the same period patient was treated with OMEPRAZOLE/SODIUM BICARBONATE (View Omeprazole/sodium Bicarbonate Review and Omeprazole/sodium Bicarbonate Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ).

5891930-2 | Bacterial Infection, Erysipelas, Immunosuppression, Pneumonia
on Sep 11, 2008 Female patient from JAPAN , 58 years of age, weighting 105.8 lb, was diagnosed with prophylaxis against gastrointestinal ulcer, rheumatoid arthritis (What is rheumatoid arthritis?), eczema (What is eczema?) and was treated with Esomeprazole (View Usage). Patient had the following side effects: bacterial infection (What is bacterial infection?), erysipelas, immunosuppression, pneumonia (What is pneumonia?). Esomeprazole dosage: . During the same period patient was treated with RHEUMATREX (View Rheumatrex Review and Rheumatrex Label ), RIMATIL (View Rimatil Review and Rimatil Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), LOXONIN (View Loxonin Review and Loxonin Label ), DERMOVATE (Optimal Dose) (View Dermovate Review and Dermovate Label ), SATOSALBE (Optimal Dose) (View Satosalbe Review and Satosalbe Label ). Patient was hospitalized.

5884791-9 | Benign Salivary Gland Neoplasm
Patient was taking Esomeprazole (View Usage). After Esomeprazole was administered, patient had the following side effects: benign salivary gland neoplasm on Sep 10, 2008 from JAPAN Additional patient health information: Female patient , 75 years of age, was diagnosed with prophylaxis against gastrointestinal ulcer and. Esomeprazole dosage: . Patient was hospitalized.

5879830-5 | Chest Pain, Condition Aggravated, Dyspnoea
Adverse event was reported on Sep 08, 2008 by a Female patient taking Esomeprazole (View Usage) (Dosage: ) was diagnosed with gastrooesophageal reflux disease and. Location: UNITED STATES , 50 years of age, Patient experienced the following unwanted or unexpected effects: chest pain (What is chest pain?), condition aggravated, dyspnoea. During the same period patient was treated with FENTANYL (View Fentanyl Review and Fentanyl Label ), CETACAINE (View Cetacaine Review and Cetacaine Label ), ALLEGRA (View Allegra Review and Allegra Label ), LEVONORGESTREL (View Levonorgestrel Review and Levonorgestrel Label ), CALTRATE (View Caltrate Review and Caltrate Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), VERSED (View Versed Review and Versed Label ), ETHINYL ESTRADIOL TAB (View Ethinyl Estradiol Tab Review and Ethinyl Estradiol Tab Label ). Patient was hospitalized.

5875239-9 | Prothrombin Time Prolonged
on Sep 05, 2008 Female patient from SPAIN , 68 years of age, was diagnosed with gastritis, thrombosis prophylaxis, hypercholesterolaemia, depression (What is depression?) and was treated with Esomeprazole (View Usage). Patient had the following side effects: prothrombin time prolonged. Esomeprazole dosage: . During the same period patient was treated with ACENOCOUMAROL (View Acenocoumarol Review and Acenocoumarol Label ), SIMVASTATIN (Started Years Ago) (View Simvastatin Review and Simvastatin Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), DULOXETINE (View Duloxetine Review and Duloxetine Label ).

5868162-7 | Dizziness, Dysstasia, Tachyarrhythmia, Tachycardia Paroxysmal, Ventricular Tachycardia
on Aug 28, 2008 Male patient from JAPAN , 72 years of age, weighting 172.0 lb, was diagnosed with reflux oesophagitis, gout (What is gout?), hypertension, insomnia and was treated with Esomeprazole (View Usage). After Esomeprazole was administered, patient had the following side effects: dizziness (What is dizziness?), dysstasia, tachyarrhythmia, tachycardia paroxysmal, ventricular tachycardia. Esomeprazole dosage: . During the same period patient was treated with ZYLORIC (View Zyloric Review and Zyloric Label ), NORVASC (View Norvasc Review and Norvasc Label ), BETAPRESSIN (View Betapressin Review and Betapressin Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ). Patient was hospitalized.

5863056-5 | Dehydration, Pyelonephritis
Patient was taking Esomeprazole (View Usage). Patient experienced the following unwanted or unexpected effects: dehydration, pyelonephritis on Aug 19, 2008 from JAPAN Additional patient health information: Female patient , 73 years of age, weighting 127.9 lb, was diagnosed with prophylaxis against gastrointestinal ulcer, rheumatoid arthritis (What is rheumatoid arthritis?), osteoporosis (What is osteoporosis?), hypertension and. Esomeprazole dosage: . During the same period patient was treated with RIMATIL (View Rimatil Review and Rimatil Label ), RHEUMATREX (View Rheumatrex Review and Rheumatrex Label ), FOLIAMIN (View Foliamin Review and Foliamin Label ), LORCAM (View Lorcam Review and Lorcam Label ), ACTONEL (View Actonel Review and Actonel Label ), ADALAT (View Adalat Review and Adalat Label ), OLMETEC (View Olmetec Review and Olmetec Label ), PREDONINE (View Predonine Review and Predonine Label ). Patient was hospitalized.

5859413-3 | Dehydration
Adverse event was reported on Aug 12, 2008 by a Female patient taking Esomeprazole (View Usage) (Dosage: ) was diagnosed with prophylaxis against gastrointestinal ulcer, osteoporosis (What is osteoporosis?), rheumatoid arthritis (What is rheumatoid arthritis?), hypertension and. Location: JAPAN , 73 years of age, weighting 127.9 lb, Patient had the following side effects: dehydration. During the same period patient was treated with ACTONEL (View Actonel Review and Actonel Label ), RIMATIL (View Rimatil Review and Rimatil Label ), RHEUMATREX (View Rheumatrex Review and Rheumatrex Label ), FOLIAMIN (View Foliamin Review and Foliamin Label ), LORCAM (View Lorcam Review and Lorcam Label ), ADALAT (View Adalat Review and Adalat Label ), OLMETEC (View Olmetec Review and Olmetec Label ), PREDONINE (View Predonine Review and Predonine Label ). Patient was hospitalized.

5858500-3 | Dehydration
on Aug 04, 2008 Female patient from JAPAN , 73 years of age, weighting 127.9 lb, was diagnosed with prophylaxis against gastrointestinal ulcer, osteoporosis (What is osteoporosis?), rheumatoid arthritis (What is rheumatoid arthritis?), hypertension and was treated with Esomeprazole (View Usage). After Esomeprazole was administered, patient had the following side effects: dehydration. Esomeprazole dosage: . During the same period patient was treated with ACTONEL (View Actonel Review and Actonel Label ), RIMATIL (View Rimatil Review and Rimatil Label ), RHEUMATREX (View Rheumatrex Review and Rheumatrex Label ), FOLIAMIN (View Foliamin Review and Foliamin Label ), LORCAM (View Lorcam Review and Lorcam Label ), ADALAT (View Adalat Review and Adalat Label ), OLMETEC (View Olmetec Review and Olmetec Label ), PREDONINE (View Predonine Review and Predonine Label ). Patient was hospitalized.

5857864-4 | Tachyarrhythmia
on Aug 21, 2008 Male patient from JAPAN , 72 years of age, weighting 172.0 lb, was diagnosed with reflux oesophagitis, gout (What is gout?), hypertension, insomnia and was treated with Esomeprazole (View Usage). Patient experienced the following unwanted or unexpected effects: tachyarrhythmia. Esomeprazole dosage: . During the same period patient was treated with ZYLORIC (View Zyloric Review and Zyloric Label ), NORVASC (View Norvasc Review and Norvasc Label ), BETAPRESSIN (View Betapressin Review and Betapressin Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ). Patient was hospitalized.

5853976-X | Erysipelas, Pneumonia
Patient was taking Esomeprazole (View Usage). Patient had the following side effects: erysipelas, pneumonia (What is pneumonia?) on Aug 14, 2008 from JAPAN Additional patient health information: Female patient , 58 years of age, weighting 105.8 lb, was diagnosed with prophylaxis against gastrointestinal ulcer, rheumatoid arthritis (What is rheumatoid arthritis?), eczema (What is eczema?) and. Esomeprazole dosage: . During the same period patient was treated with RHEUMATREX (View Rheumatrex Review and Rheumatrex Label ), RIMATIL (View Rimatil Review and Rimatil Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), LOXONIN (View Loxonin Review and Loxonin Label ), DERMOVATE (Optimal Dose) (View Dermovate Review and Dermovate Label ), SATOSALBE (Optimal Dose) (View Satosalbe Review and Satosalbe Label ). Patient was hospitalized.

5843267-5 | Dehydration
Adverse event was reported on Aug 04, 2008 by a Female patient taking Esomeprazole (View Usage) (Dosage: ) was diagnosed with prophylaxis against gastrointestinal ulcer, osteoporosis (What is osteoporosis?), rheumatoid arthritis (What is rheumatoid arthritis?), hypertension and. Location: JAPAN , 73 years of age, weighting 127.9 lb, After Esomeprazole was administered, patient had the following side effects: dehydration. During the same period patient was treated with ACTONEL (View Actonel Review and Actonel Label ), RIMATIL (View Rimatil Review and Rimatil Label ), RHEUMATREX (View Rheumatrex Review and Rheumatrex Label ), FOLIAMIN (View Foliamin Review and Foliamin Label ), LORCAM (View Lorcam Review and Lorcam Label ), ADALAT (View Adalat Review and Adalat Label ), OLMESARTAN MEDOXOMIL (View Olmesartan Medoxomil Review and Olmesartan Medoxomil Label ), PREDONINE (View Predonine Review and Predonine Label ). Patient was hospitalized.

5833110-2 | Serotonin Syndrome
on Jul 25, 2008 Female patient from UNITED STATES , 46 years of age, was diagnosed with depression (What is depression?) and was treated with Esomeprazole (View Usage). Patient experienced the following unwanted or unexpected effects: serotonin syndrome. Esomeprazole dosage: . During the same period patient was treated with CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), ZOLPIDEM CONTROLLED RELEASE (Nightly) (View Zolpidem Controlled Release Review and Zolpidem Controlled Release Label ), LOSARTAN/HYDROCHLOROTHIAZIDE (50mg/12.5mg) (View Losartan/hydrochlorothiazide Review and Losartan/hydrochlorothiazide Label ), DAPSONE (View Dapsone Review and Dapsone Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ). Patient was hospitalized.

5825352-7 | Gastric Cancer
on Jul 14, 2008 Female patient from JAPAN , weighting 121.3 lb, was diagnosed with spinal column stenosis, osteoarthritis (What is osteoarthritis?), hepatic steatosis, constipation (What is constipation?), hypertension and was treated with Esomeprazole (View Usage). Patient had the following side effects: gastric cancer. Esomeprazole dosage: . During the same period patient was treated with MOHRUS TAPE (View Mohrus Tape Review and Mohrus Tape Label ), OPALMON (View Opalmon Review and Opalmon Label ), LOXONIN (View Loxonin Review and Loxonin Label ), SUVENYL (View Suvenyl Review and Suvenyl Label ), URSO 250 (View Urso 250 Review and Urso 250 Label ), LAXOBERON (View Laxoberon Review and Laxoberon Label ), AMLODIN (View Amlodin Review and Amlodin Label ), NU LOTAN (View Nu-lotan Review and Nu-lotan Label ).

5825322-9 | Oesophagitis
Patient was taking Esomeprazole (View Usage). After Esomeprazole was administered, patient had the following side effects: oesophagitis on Jul 16, 2008 from JAPAN Additional patient health information: Female patient , weighting 114.6 lb, was diagnosed with reflux oesophagitis, constipation (What is constipation?) and. Esomeprazole dosage: . During the same period patient was treated with PURSENNID (As Required) (View Pursennid Review and Pursennid Label ), LAXOBERON (Optimal Dose As Required) (View Laxoberon Review and Laxoberon Label ). Patient was hospitalized.

5753706-6 | Arteritis, Gastrointestinal Perforation, Liver Disorder, Necrosis, Paraesthesia, Pyelonephritis
Adverse event was reported on May 22, 2008 by a Female patient taking Esomeprazole (View Usage) (Dosage: ) was diagnosed with prophylaxis against gastrointestinal ulcer, osteoarthritis (What is osteoarthritis?), eczema (What is eczema?), lumbar spinal stenosis, hyperlipidaemia, cataract (What is cataract?) and. Location: JAPAN , 68 years of age, weighting 116.8 lb, Patient experienced the following unwanted or unexpected effects: arteritis, gastrointestinal perforation, liver disorder, necrosis, paraesthesia, pyelonephritis. During the same period patient was treated with MOBIC (View Mobic Review and Mobic Label ), MYSER (View Myser Review and Myser Label ), OPALMON (View Opalmon Review and Opalmon Label ), LIPITOR (View Lipitor Review and Lipitor Label ), ARTZ DISPO (1 Dose Form/2 Weeks) (View Artz Dispo Review and Artz Dispo Label ), XYLOCAINE (Ni/2 Weeks) (View Xylocaine Review and Xylocaine Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), KARY UNI (View Kary Uni Review and Kary Uni Label ). Patient was hospitalized.

5722450-3 | Abdominal Distension, Blood Cholesterol Increased, Blood Pressure Increased, Face Oedema, Oedema Peripheral
on Jun 28, 2007 Female patient from UNITED STATES , 54 years of age, weighting 100.1 lb, was diagnosed with gastrooesophageal reflux disease and was treated with Esomeprazole (View Usage). Patient had the following side effects: abdominal distension, blood cholesterol increased, blood pressure increased, face oedema, oedema peripheral. Esomeprazole dosage: Took Nexium For 2 To 5 Days During The Week Of June 2, 2007. During the same period patient was treated with LIPITOR (View Lipitor Review and Lipitor Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

5721561-6 | Nephritis Interstitial
on Apr 16, 2007 Male patient from UNITED STATES , 63 years of age, was treated with Esomeprazole (View Usage). After Esomeprazole was administered, patient had the following side effects: nephritis interstitial. Esomeprazole dosage: . During the same period patient was treated with TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN (View Tramadol Hydrochloride And Acetaminophen Review and Tramadol Hydrochloride And Acetaminophen Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), CALCITRIOL (View Calcitriol Review and Calcitriol Label ). Patient was hospitalized.

5711614-0 | Myocardial Infarction
Patient was taking Esomeprazole (View Usage). Patient experienced the following unwanted or unexpected effects: myocardial infarction on Apr 10, 2008 from UNITED KINGDOM Additional patient health information: Male patient , 37 years of age, was diagnosed with deep vein thrombosis (What is deep vein thrombosis?) and. Esomeprazole dosage: . During the same period patient was treated with WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ).

5601461-2 | Liver Disorder, Pyelonephritis
Adverse event was reported on Jan 10, 2008 by a Female patient taking Esomeprazole (View Usage) (Dosage: ) was diagnosed with prophylaxis against gastrointestinal ulcer, osteoarthritis (What is osteoarthritis?), eczema (What is eczema?), lumbar spinal stenosis, hyperlipidaemia, cataract (What is cataract?), nasopharyngitis and. Location: JAPAN , weighting 116.8 lb, Patient had the following side effects: liver disorder, pyelonephritis. During the same period patient was treated with MOBIC (View Mobic Review and Mobic Label ), MYSER (View Myser Review and Myser Label ), OPALMON (View Opalmon Review and Opalmon Label ), LIPITOR (View Lipitor Review and Lipitor Label ), ARTZ DISPO (View Artz Dispo Review and Artz Dispo Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), KARY UNI (View Kary Uni Review and Kary Uni Label ), PRECOL (View Precol Review and Precol Label ). Patient was hospitalized.

5527996-9 | Rhabdomyolysis
on Nov 21, 2007 Male patient from GERMANY , 75 years of age, was treated with Esomeprazole (View Usage). After Esomeprazole was administered, patient had the following side effects: rhabdomyolysis. Esomeprazole dosage: .

5053744-5 | Muscle Atrophy, Myalgia, Myopathy
on Jul 07, 2006 Male patient from NEW ZEALAND , 70 years of age, was treated with Esomeprazole (View Usage). Patient experienced the following unwanted or unexpected effects: muscle atrophy, myalgia, myopathy. Esomeprazole dosage: Stopped Due To Adverse Event.

5040587-1 | Acidosis, Hepatitis, Respiratory Failure
Patient was taking Esomeprazole (View Usage). Patient had the following side effects: acidosis, hepatitis (What is hepatitis?), respiratory failure on Mar 15, 2006 from FRANCE Additional patient health information: Male patient , 76 years of age, was diagnosed with insulin-requiring type ii diabetes mellitus and. Esomeprazole dosage: . During the same period patient was treated with NOVONORM (8.5 Mg, Unk) (View Novonorm Review and Novonorm Label ), CIFLOX (500 Mg, Qd) (View Ciflox Review and Ciflox Label ), HALDOL (20 Mg, Qd) (View Haldol Review and Haldol Label ), CORTANCYL (30 Mg, Qd) (View Cortancyl Review and Cortancyl Label ), TRIFLUCAN (400 Mg, Qd) (View Triflucan Review and Triflucan Label ), ZELITREX /DEN/ (View Zelitrex /den/ Review and Zelitrex /den/ Label ), LANTUS (View Lantus Review and Lantus Label ). Patient was hospitalized.

5040186-1 | Hypersensitivity, Immune System Disorder, Nephritis Interstitial, Renal Failure Acute
Adverse event was reported on Jun 21, 2006 by a Female patient taking Esomeprazole (View Usage) (Dosage: Taken For 3 Weeks At Time Of Diagnosis.) was diagnosed with gastrooesophageal reflux disease and. Location: AUSTRALIA , 63 years of age, After Esomeprazole was administered, patient had the following side effects: hypersensitivity, immune system disorder, nephritis interstitial, renal failure acute. During the same period patient was treated with ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), IRBESARTAN (View Irbesartan Review and Irbesartan Label ).

5038835-7 | Anaemia, Balance Disorder, Hypersensitivity, Immune System Disorder, Leukocytosis, Nephritis Interstitial, Renal Failure Acute
on Jun 21, 2006 Female patient from AUSTRALIA , 83 years of age, was diagnosed with dyspepsia and was treated with Esomeprazole (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, balance disorder, hypersensitivity, immune system disorder, leukocytosis, nephritis interstitial, renal failure acute. Esomeprazole dosage: Taken For 16 Weeks At Time Of Diagnosis.. During the same period patient was treated with AMITRIPTYLINE HCL (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ), CALCIUM GLUCONATE (View Calcium Gluconate Review and Calcium Gluconate Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), DISODIUM ETIDRONATE (View Disodium Etidronate Review and Disodium Etidronate Label ), IRON (View Iron Review and Iron Label ).

5007019-0 | Acidosis, Hepatitis, Hepatitis Acute, Respiratory Failure
on Mar 15, 2006 Male patient from FRANCE , 76 years of age, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with Esomeprazole (View Usage). Patient had the following side effects: acidosis, hepatitis (What is hepatitis?), hepatitis acute, respiratory failure. Esomeprazole dosage: . During the same period patient was treated with NOVONORM (8.5 Mg, Unk) (View Novonorm Review and Novonorm Label ), CIFLOX (500 Mg, Qd) (View Ciflox Review and Ciflox Label ), HALDOL (20 Mg, Qd) (View Haldol Review and Haldol Label ), CORTANCYL (30 Mg, Qd) (View Cortancyl Review and Cortancyl Label ), TRIFLUCAN (400 Mg, Qd) (View Triflucan Review and Triflucan Label ), ZELITREX /DEN/ (View Zelitrex /den/ Review and Zelitrex /den/ Label ), LANTUS (View Lantus Review and Lantus Label ). Patient was hospitalized.

4976205-8 | Acidosis, Hepatitis, Respiratory Failure
Patient was taking Esomeprazole (View Usage). After Esomeprazole was administered, patient had the following side effects: acidosis, hepatitis (What is hepatitis?), respiratory failure on Mar 15, 2006 from FRANCE Additional patient health information: Male patient , 76 years of age, was diagnosed with insulin-requiring type ii diabetes mellitus and. Esomeprazole dosage: . During the same period patient was treated with NOVONORM (8.5 Mg, Unk) (View Novonorm Review and Novonorm Label ), CIFLOX (500 Mg, Qd) (View Ciflox Review and Ciflox Label ), HALDOL (20 Mg, Qd) (View Haldol Review and Haldol Label ), CORTANCYL (30 Mg, Qd) (View Cortancyl Review and Cortancyl Label ), TRIFLUCAN (400 Mg, Qd) (View Triflucan Review and Triflucan Label ), ZELITREX /DEN/ (View Zelitrex /den/ Review and Zelitrex /den/ Label ), LANTUS (View Lantus Review and Lantus Label ). Patient was hospitalized.

4928606-1 | Confusional State, Hallucination
Adverse event was reported on Feb 22, 2006 by a Female patient taking Esomeprazole (View Usage) (Dosage: ) was diagnosed with gastritis, urinary tract infection (What is urinary tract infection?) and. Location: UNITED KINGDOM , 89 years of age, Patient experienced the following unwanted or unexpected effects: confusional state, hallucination. During the same period patient was treated with TRIMETHOPRIM (View Trimethoprim Review and Trimethoprim Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), FRUSEMIDE (View Frusemide Review and Frusemide Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), AMITRIPTYLINE HCL (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ), PERINDOPRIL (View Perindopril Review and Perindopril Label ). Patient was hospitalized.

4773989-9 | Arthralgia, Rash, Wheezing
on Sep 12, 2005 Male patient from UNITED KINGDOM , 53 years of age, was diagnosed with dyspepsia, helicobacter infection and was treated with Esomeprazole (View Usage). Patient had the following side effects: arthralgia, rash (What is rash?), wheezing. Esomeprazole dosage: . During the same period patient was treated with LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ).

4688022-7 | Cardiac Flutter, Extrasystoles
on Jun 06, 2005 Female patient from , 56 years of age, weighting 156.5 lb, was diagnosed with duodenal ulcer and was treated with Esomeprazole (View Usage). After Esomeprazole was administered, patient had the following side effects: cardiac flutter, extrasystoles. Esomeprazole dosage: .

4672453-5 | Antibody Test Abnormal, C-reactive Protein Increased, Hypergammaglobulinaemia, Hyperproteinaemia, Lymphadenopathy, Lymphocytic Infiltration, Lymphocytosis, Prurigo
Patient was taking Esomeprazole (View Usage). Patient experienced the following unwanted or unexpected effects: antibody test abnormal, c-reactive protein increased, hypergammaglobulinaemia, hyperproteinaemia, lymphadenopathy, lymphocytic infiltration, lymphocytosis, prurigo on Apr 11, 2005 from Additional patient health information: Male patient , 84 years of age, weighting 134.5 lb, was diagnosed with gastritis, osteoarthritis (What is osteoarthritis?), hypertension and. Esomeprazole dosage: 1 Df, Qd. During the same period patient was treated with VOLTAREN (75 Mg, Qd) (View Voltaren Review and Voltaren Label ), AVLOCARDYL (40 Mg, Bid) (View Avlocardyl Review and Avlocardyl Label ), COTAREG (1 Df, Qd) (View Cotareg Review and Cotareg Label ). Patient was hospitalized.

4666386-8 | Depressed Level Of Consciousness, Hyponatraemia, Inappropriate Antidiuretic Hormone Secretion, Lethargy
Adverse event was reported on Apr 11, 2005 by a Female patient taking Esomeprazole (View Usage) (Dosage: ) was diagnosed with gastrooesophageal reflux disease, hypertension and. Location: , 81 years of age, Patient had the following side effects: depressed level of consciousness, hyponatraemia, inappropriate antidiuretic hormone secretion, lethargy. During the same period patient was treated with SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ). Patient was hospitalized.

4645765-9 | Inappropriate Antidiuretic Hormone Secretion
on Apr 11, 2005 Female patient from , 81 years of age, was diagnosed with gastrooesophageal reflux disease and was treated with Esomeprazole (View Usage). After Esomeprazole was administered, patient had the following side effects: inappropriate antidiuretic hormone secretion. Esomeprazole dosage: 20 Mg Daily. During the same period patient was treated with SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ).

4561131-9 | Dyspnoea, Hypocalcaemia, Hypokalaemia, Hypophosphataemia, Malaise, Muscular Weakness, Nephritis Interstitial, Renal Tubular Acidosis
on Jan 18, 2005 Male patient from , 33 years of age, weighting 165.3 lb, was diagnosed with duodenal ulcer and was treated with Esomeprazole (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea, hypocalcaemia, hypokalaemia, hypophosphataemia, malaise, muscular weakness, nephritis interstitial, renal tubular acidosis. Esomeprazole dosage: 40 Mg Qd Po. Patient was hospitalized.